Skip to main content
. 2017 Jun 9;49(6):e344. doi: 10.1038/emm.2017.74

Figure 6.

Figure 6

The tumorigenic potential of nicotinamide nucleotide transhydrogenase (NNT) overexpression or knockdown in SSEA1+ tumor-initiating cells is shown. (a) Control (Con), retroviral NNT-transduced or short interfering RNA for NNT (siNNT)-transfected U373MG SSEA1+ cells were injected subcutaneously and tumors were excised at 6 weeks after injection. Representative images of excised tumor mass in each group were shown. (b) Tumor volume was measured daily after tumor mass detected. (c) Intracranial orthotopic injection of control or siNNT-transfected U373MG SSEA1+ cells. Representative hematoxylin and eosin images of each two mice brain (upper and lower) and higher magnification of each section (each right in group). (d) Tumor area was quantified. (e) Immunohistochemistry of Sox2 and Nestin in each brain. 4,6-Diamidino-2-phenylindole (DAPI) staining (blue) was used to identify nuclei. *P<0.05; **P<0.01; ***P<0.001 (Student’s t-test).